# BIMZELX
> **BLA761151** · Biologics License Application · Sponsor: UCB INC · Approved 2023-10-17
## Drug
- **FDA Application Number:** BLA761151
- **Application type:** Biologics License Application
- **Brand name:** BIMZELX
- **Generic name:** BIMEKIZUMAB
- **Active ingredients:** BIMEKIZUMAB-BKZX
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** UCB INC
- **Manufacturer:** UCB, Inc.
- **First approval:** 2023-10-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761151)
---
*AI Analytics · CC0 1.0*